Innovation protecting tomorrow

Partner with us, license a technology, or innovate locally here in New Mexico.

Request for Information: Advanced Tissue-engineered Human Ectypal Networks Analyzer (ATHENA)

Commercialization Opportunity

LANS is opening this Request for Information to gauge interest in engaging as an industry partnerwith LANS for collaboration in advancing a next-gen in vitro platform for lead compound and toxicity screening.

Submit your response by email to athena@lanl.gov by 11:59 PM MST on Friday, May 27, 2016.

Background and Technology Description

Over the past 3+ years, Los Alamos scientists have developed a milli-scale surrogate human organ bioreactor, coupled with highly sensitive analytical technologies. Dubbed the Advanced Tissue-engineered Human Ectypal Networks Analyzer (ATHENA), the platform is a human organ construct developed for screening of lead compounds, testing of medical countermeasures, and toxicity testing.

Learn more »

Technology Opportunities

Periodically the Laboratory notifies the public of technologies and capabilities that may be of interest.  These technologies may extend from recent inventions, technology opportunity or capabilities that may have utility outside the Laboratory.  If you are interested in any of the following LANS capabilities, please contact the Business Development Team.

Visit Blogger Join Us on Facebook Follow Us on Twitter See our Flickr Photos Watch Our YouTube Videos Find Us on LinkedIn Find Us on iTunesFind Us on GooglePlay